Viral hepatitis – News, Research and Analysis – The Conversation

Articles on Viral hepatitis

May 26, 2021

Pasha 108: Some good news in the fight against hepatitis C in Africa

Ozayr Patel, The Conversation

New direct-acting antiviral drugs would work successfully in countries where numerous different strains of hepatitis C are found.

August 2, 2020

Pauline Bakibinga, African Population and Health Research Center and Aheisibwe Hillary, Mbarara University of Science and Technology

HIV/AIDS receives more funding than hepatitis, which is responsible for more deaths.

October 24, 2019

Peter Revill, The Peter Doherty Institute for Infection and Immunity and Margaret Littlejohn, Melbourne Health

Babies in Australia have been vaccinated against hepatitis B since May 2000, but 240,000 Australians still live with the disease.

February 14, 2018

Bob Mash, Stellenbosch University; Hassan Mahomed, Stellenbosch University, and Shrikant Peters, University of Cape Town

When day zero arrives in Cape Town, the routine surveillance systems that monitor disease outbreaks will be enhanced to pick up new diseases.

Bob Mash
Distinguished Professor, Division of Family Medicine and Primary Care, Stellenbosch University
Hassan Mahomed
Public Health Specialist in the Division of Health Systems and Public Health,, Stellenbosch University
Shrikant Peters
Public Health Registrar in the Division of Public Health Medicine, University of Cape Town
John McLauchlan
Professor of Viral Hepatitis, University of Glasgow
Margaret Littlejohn
Medical Scientist, Melbourne Health
Pauline Bakibinga
Associate Research Scientist, African Population and Health Research Center
Peter Revill
Senior Medical Scientist at VIDRL, Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity
Aheisibwe Hillary
Obstetrician and Gynecologist, Mbarara University of Science and Technology
Elihu Aranday-Cortes
Research Associate (Centre for Virus Research), University of Glasgow